These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7854084)
1. [Relative risk of hepatitis C virus transmission in polytransfused patients]. Schujman L; Lavitula S; Maris Acebal S; Suita GR; Montero A Medicina (B Aires); 1994; 54(3):199-202. PubMed ID: 7854084 [TBL] [Abstract][Full Text] [Related]
2. [Anti-HCV in patients undergoing dialysis in Piedmont and in Valle d'Aosta]. Giachino G; Francisco M; Guasti GC; Reinero G; Saltarelli M; Morello M Minerva Urol Nefrol; 1991; 43(3):201-4. PubMed ID: 1667881 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs non-dialyzed patients. Kumar H; Naqvi SA; Ahmed A; Hamid S J Pak Med Assoc; 1994 Feb; 44(2):28-30. PubMed ID: 8040988 [TBL] [Abstract][Full Text] [Related]
5. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members]. Miyasaka M Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus antibodies among risk groups in Turkey. Köksal I; Biberoğlu K; Biberoğlu S; Koç F; Ayma Y; Aker F; Köksal H Infection; 1991; 19(4):228-9. PubMed ID: 1917033 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay. Mondelli MU; Cristina G; Piazza V; Cerino A; Villa G; Salvadeo A Nephron; 1992; 61(3):350-1. PubMed ID: 1323788 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus in dialysis units: a multicenter study. Da Porto A; Adami A; Susanna F; Calzavara P; Poli P; Castelletto MR; Amici GP; Teodori T; Okolicsanyi L Nephron; 1992; 61(3):309-10. PubMed ID: 1323777 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C: reality of a renal unit. Bracchi O; Orazi E; Lupi GP; Bronzieri C; Cornalba L; Grassi C Nephron; 1992; 61(3):369-70. PubMed ID: 1323795 [TBL] [Abstract][Full Text] [Related]
10. Seropositivity to hepatitis C virus (HCV) in Saudi children with chronic renal failure maintained on haemodialysis. al-Mugeiren M; al-Faleh FZ; Ramia S; al-Rasheed S; Mahmoud MA; al-Nasser M Ann Trop Paediatr; 1992; 12(2):217-9. PubMed ID: 1381899 [TBL] [Abstract][Full Text] [Related]
11. [A seroprevalence study of the hepatitis C virus among multiply transfused patients]. Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483 [TBL] [Abstract][Full Text] [Related]
12. [The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients]. Motta M; Brischetto R; Rapisarda F; Corno C; Rapisarda C; Fatuzzo P; Messina A; Biondi A; Mezzasalma E; Calcara G Ann Ital Med Int; 1991; 6(4):375-8. PubMed ID: 1666516 [TBL] [Abstract][Full Text] [Related]
13. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study. Medin C; Allander T; Roll M; Jacobson SH; Grillner L Nephron; 1993; 65(1):40-5. PubMed ID: 7692314 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C infection in a pediatric dialysis population. Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169 [TBL] [Abstract][Full Text] [Related]
17. [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables]. Padrone M; Corallini O; Cocozzella D; Malca M; Borzi S; Barrio M; Adrover RE; Cuffini AM; Gomez C; Giamona AM; Brawlasky G; Newmann P; Dell Amo M; Fraquelli E; Curciarello JO Acta Gastroenterol Latinoam; 1999; 29(3):91-4. PubMed ID: 10533653 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811 [TBL] [Abstract][Full Text] [Related]
19. [The importance of the blood transfusion factor in the epidemic process in hepatitis C in the patients of chronic hemodialysis units studied using a computer simulation model]. Savin EA; Kuzin SN; Blinov VM; Loparev VN; Sukhanova LL; Gol'tsov VA; Ershova GN; Viazov SO; Shakhgil'dian IV Vopr Virusol; 1993; 38(3):135-7. PubMed ID: 8073753 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors. Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M Nephron; 1992; 61(3):346. PubMed ID: 1323786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]